Acumen Hypotension Prediction Index (HPI) Feature Software vs DeepRhythmAI

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
by Medicalgorithmics

AI Verdict

Tool A, Acumen HPI, is designed for real-time prediction and proactive management of hypotensive events using blood pressure waveforms in acute care settings. In contrast, Tool B, DeepRhythmAI, focuses on the accurate detection and classification of cardiac arrhythmias from ECG data to enhance diagnostic efficiency in cardiology. While both are categorized under Cardiology AI, their distinct clinical applications and data inputs make them suitable for different needs within cardiovascular care.

Choose Acumen Hypotension Prediction Index (HPI) Feature Software if…

Choose Acumen HPI if your primary concern is proactive, real-time hemodynamic management in acute care settings. This tool is ideal for anesthesiologists, critical care, and emergency medicine clinicians who need to predict and prevent hypotensive events up to 15 minutes before they occur, thereby improving patient stability and outcomes during procedures or critical illness.

View Acumen Hypotension Prediction Index (HPI) Feature Software →

Choose DeepRhythmAI if…

Choose DeepRhythmAI if your focus is on highly accurate and efficient detection and classification of cardiac arrhythmias from ECG data. This cloud-based solution is best suited for cardiologists and healthcare providers seeking to streamline ECG analysis, reduce missed diagnoses of various arrhythmias, and improve diagnostic workflow efficiency across a range of ECG devices.

View DeepRhythmAI →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Acumen Hypotension Prediction Index (HPI) Feature Software DeepRhythmAI
Pricing Unknown Contact vendor for pricing information
Deployment Unknown Cloud-based, hardware-agnostic, SaaS, on-prem, hybrid
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

DeepRhythmAI

DeepRhythmAI offers broader usability with its device-agnostic, cloud-based deployment and API availability, allowing for seamless integration across various ECG devices and healthcare systems. It also explicitly claims to streamline clinical workflows by up to 65% and features an intuitive user interface.

Clinical Value

DeepRhythmAI

Both tools offer significant clinical benefits, but DeepRhythmAI's quantifiable claim of reducing missed diagnoses by '14x to 114x fewer' and its training on an immense dataset of '250 billion+ annotated heartbeats' demonstrates a profound impact on diagnostic accuracy. Acumen HPI also shows strong clinical value with a demonstrated 57% reduction in the duration of intraoperative hypotension.

Pricing & Value

Tie

Both tools maintain opaque pricing models, requiring direct contact with the vendor for specific information. Without publicly available pricing details, it is impossible to conduct a meaningful head-to-head comparison of their cost-effectiveness or overall value proposition.

Enterprise Readiness

DeepRhythmAI

DeepRhythmAI demonstrates superior enterprise readiness with its comprehensive list of compliance certifications (HIPAA, GDPR, HITECH, SOC 2, ISO 27001), flexible deployment options (SaaS, on-prem, hybrid), and explicit API availability for seamless integration into diverse IT environments.

Innovation

Tie

Both tools represent significant innovation in their respective fields. Acumen HPI is described as a 'first-of-its-kind technology' for predictive hypotension, offering proactive patient management. DeepRhythmAI leverages advanced AI models (CNN and Transformer) and an exceptionally large dataset for superior arrhythmia detection, pushing the boundaries of diagnostic accuracy.

Support & Docs

Acumen Hypotension Prediction Index (HPI) Feature Software

While both companies offer standard contact methods for support, Edwards Lifesciences explicitly highlights the availability of 'Instructions For Use / Operator's Manual' and 'Clinical and Medical Affairs' resources, suggesting a more robust and readily accessible documentation suite for its users.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Acumen Hypotension Prediction Index (HPI) Feature Software DeepRhythmAI
Product Name Acumen Hypotension Prediction Index (HPI) Feature Software DeepRhythmAI
Company Edwards Lifesciences Medicalgorithmics S.A.
Primary Use Case Predictive monitoring tool using machine learning to detect and alert clinicians to the likelihood of a hypotensive event before it occurs, aiding in proactive hemodynamic management. AI algorithm for cardiac arrhythmia detection and classification from ECG data, offering superior accuracy and efficiency for physicians.
Categories Cardiology AI, Triage & ER/ICU AI Cardiology AI, Clinical Decision Support & Reference
Specialties Anesthesiology, Critical Care, Emergency Medicine Cardiology
Key AI Mechanism/Data Machine learning algorithms for predictive analysis of blood pressure waveforms; predicts hypotension up to 15 minutes before an event. Utilizes CNN and Transformer models; trained on 250 billion+ annotated heartbeats.

Videos

Demos, reviews, and walkthroughs featuring Acumen Hypotension Prediction Index (HPI) Feature Software and DeepRhythmAI.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Acumen Hypotension Prediction Index (HPI) Feature Software is designed to predict and alert clinicians to the likelihood of a hypotensive event before it occurs, aiding in proactive hemodynamic management. DeepRhythmAI, on the other hand, revolutionizes cardiac arrhythmia detection and classification from ECG data, offering superior accuracy and efficiency for physicians.
Acumen HPI is primarily intended for Anesthesiology, Critical Care, and Emergency Medicine. DeepRhythmAI is specifically designed to support Cardiology.
Acumen HPI is integrated into Edwards Lifesciences' HemoSphere advanced monitoring platform. DeepRhythmAI is a cloud-based software that is device-agnostic and integrates with various ECG devices, supporting data from Holter, Event recorders, and Outpatient Cardiac Telemetry.
Acumen HPI utilizes machine learning algorithms for predictive analysis of blood pressure waveforms, compatible with both invasive (arterial line) and non-invasive (Acumen IQ cuff) monitoring. DeepRhythmAI analyzes ECG data, including from single- or two-lead ECGs, Holter, Event recorders, and Mobile Cardiac Telemetry devices.
Acumen HPI has demonstrated a reduction in the incidence, duration, and severity of intraoperative hypotension. DeepRhythmAI offers superior accuracy and efficiency, reducing missed diagnoses by 14x to 114x and streamlining clinical workflows by up to 65%.
Acumen HPI uses machine learning algorithms to analyze blood pressure waveforms and generate a Hypotension Prediction Index (HPI) parameter (0-100 score) to predict hypotension up to 15 minutes before an event. DeepRhythmAI employs AI-powered Convolutional Neural Networks (CNN) and Transformer models, trained on over 250 billion annotated heartbeats, for accurate arrhythmia detection and classification.
Both Acumen HPI and DeepRhythmAI are FDA cleared. Additionally, Acumen HPI is HIPAA compliant and has a Business Associate Agreement (BAA) available.
AI Tool Finder
AI-powered search. Results may not be comprehensive.